一名感染人类免疫缺陷病毒的男性在进行利福平斑贴试验后，出现药物疹伴嗜酸性粒细胞增多和全身症状综合征的严重复发。 - Suppr

Suppr

超能文献

Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.

作者信息

Shebe Khadija, Ngwanya Mzudumile R, Gantsho Nomphelo, Lehloenya Rannakoe J

机构信息

Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, 7925, South Africa.

出版信息

Contact Dermatitis. 2014 Feb;70(2):125-7. doi: 10.1111/cod.12155.

DOI:10.1111/cod.12155

PMID:24450829

Abstract

摘要

相似文献

Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.

Contact Dermatitis. 2014 Feb;70(2):125-7. doi: 10.1111/cod.12155.

[Severe hypercalcemia in a patient treated with fluconazole and rifampicin].

Presse Med. 1998 May 16;27(18):860.

Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.

Clin Infect Dis. 1998 Nov;27(5):1329-30.

Reactivation of Skin Lesions After Patch Testing to Investigate Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Actas Dermosifiliogr. 2016 Nov;107(9):781-783. doi: 10.1016/j.ad.2016.05.006. Epub 2016 Jun 20.

[Rifampicin toxicity in HIV-infected patients: A study of its incidence and the risk factors].

An Med Interna. 1997 Nov;14(11):559-64.

[Hemolytic anemia secondary to rifampicin in patient diagnosed of pulmonary tuberculosis reinfection].

Rev Esp Quimioter. 2013 Dec;26(4):369-70.

Pharmacokinetics interaction studies between rifampicin and protease inhibitors: methodological problems.

AIDS. 2008 Oct 1;22(15):2046-7. doi: 10.1097/QAD.0b013e3283112bb7.

Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.

Contact Dermatitis. 2022 Jun;86(6):443-479. doi: 10.1111/cod.14090. Epub 2022 Mar 29.

DRESS syndrome induced by rifampicin.

Therapie. 2018 Oct;73(5):441-443. doi: 10.1016/j.therap.2018.02.009. Epub 2018 Mar 3.

[DRESS syndrome secondary to antituberculosis drugs: about a case].

Pan Afr Med J. 2017 May 11;27:37. doi: 10.11604/pamj.2017.27.37.11663. eCollection 2017.

引用本文的文献

Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper.

Pediatr Allergy Immunol. 2025 Jul;36(7):e70103. doi: 10.1111/pai.70103.

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions.

Front Med (Lausanne). 2022 Oct 13;9:923991. doi: 10.3389/fmed.2022.923991. eCollection 2022.

Characterizing DRESS syndrome recurrence: a systematic review.

Arch Dermatol Res. 2022 Oct;314(8):721-728. doi: 10.1007/s00403-021-02274-3. Epub 2021 Sep 10.

Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

J Allergy Clin Immunol Pract. 2020 Oct;8(9):2878-2895.e6. doi: 10.1016/j.jaip.2020.07.005.

Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study.

Allergy Asthma Immunol Res. 2019 Jan;11(1):90-103. doi: 10.4168/aair.2019.11.1.90.

The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1341-1343.e1. doi: 10.1016/j.jaip.2018.09.014. Epub 2018 Sep 26.

Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome.

BMJ Case Rep. 2017 Aug 7;2017:bcr-2017-220440. doi: 10.1136/bcr-2017-220440.

Recent advances in the understanding of severe cutaneous adverse reactions.

Br J Dermatol. 2017 Nov;177(5):1234-1247. doi: 10.1111/bjd.15423. Epub 2017 Sep 29.

AdDRESSing T-cell responses to antituberculous drugs.

Br J Dermatol. 2017 Feb;176(2):292-293. doi: 10.1111/bjd.15167.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.

作者信息

Shebe Khadija, Ngwanya Mzudumile R, Gantsho Nomphelo, Lehloenya Rannakoe J

机构信息

Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, 7925, South Africa.

出版信息

Contact Dermatitis. 2014 Feb;70(2):125-7. doi: 10.1111/cod.12155.

DOI:10.1111/cod.12155

PMID:24450829

Abstract

摘要

相似文献

Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.

Contact Dermatitis. 2014 Feb;70(2):125-7. doi: 10.1111/cod.12155.

[Severe hypercalcemia in a patient treated with fluconazole and rifampicin].

Presse Med. 1998 May 16;27(18):860.

Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.

Clin Infect Dis. 1998 Nov;27(5):1329-30.

Reactivation of Skin Lesions After Patch Testing to Investigate Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Actas Dermosifiliogr. 2016 Nov;107(9):781-783. doi: 10.1016/j.ad.2016.05.006. Epub 2016 Jun 20.

[Rifampicin toxicity in HIV-infected patients: A study of its incidence and the risk factors].

An Med Interna. 1997 Nov;14(11):559-64.

[Hemolytic anemia secondary to rifampicin in patient diagnosed of pulmonary tuberculosis reinfection].

Rev Esp Quimioter. 2013 Dec;26(4):369-70.

Pharmacokinetics interaction studies between rifampicin and protease inhibitors: methodological problems.

AIDS. 2008 Oct 1;22(15):2046-7. doi: 10.1097/QAD.0b013e3283112bb7.

Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.

Contact Dermatitis. 2022 Jun;86(6):443-479. doi: 10.1111/cod.14090. Epub 2022 Mar 29.

DRESS syndrome induced by rifampicin.

Therapie. 2018 Oct;73(5):441-443. doi: 10.1016/j.therap.2018.02.009. Epub 2018 Mar 3.

[DRESS syndrome secondary to antituberculosis drugs: about a case].

Pan Afr Med J. 2017 May 11;27:37. doi: 10.11604/pamj.2017.27.37.11663. eCollection 2017.

引用本文的文献

Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper.

Pediatr Allergy Immunol. 2025 Jul;36(7):e70103. doi: 10.1111/pai.70103.

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions.

Front Med (Lausanne). 2022 Oct 13;9:923991. doi: 10.3389/fmed.2022.923991. eCollection 2022.

Characterizing DRESS syndrome recurrence: a systematic review.

Arch Dermatol Res. 2022 Oct;314(8):721-728. doi: 10.1007/s00403-021-02274-3. Epub 2021 Sep 10.

Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

J Allergy Clin Immunol Pract. 2020 Oct;8(9):2878-2895.e6. doi: 10.1016/j.jaip.2020.07.005.

Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study.

Allergy Asthma Immunol Res. 2019 Jan;11(1):90-103. doi: 10.4168/aair.2019.11.1.90.

The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1341-1343.e1. doi: 10.1016/j.jaip.2018.09.014. Epub 2018 Sep 26.

Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome.

BMJ Case Rep. 2017 Aug 7;2017:bcr-2017-220440. doi: 10.1136/bcr-2017-220440.

Recent advances in the understanding of severe cutaneous adverse reactions.

Br J Dermatol. 2017 Nov;177(5):1234-1247. doi: 10.1111/bjd.15423. Epub 2017 Sep 29.

AdDRESSing T-cell responses to antituberculous drugs.

Br J Dermatol. 2017 Feb;176(2):292-293. doi: 10.1111/bjd.15167.